MedTrace Logo

Insecticide Resistance Management in Burkina Faso and Côte D'Ivoire

NCT03074435 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 15776

Last updated 2024-10-01

No results posted yet for this study

Summary

This study evaluates the benefit to use 1) insecticide residual sprayings, 2) larvicides, 3) Ivermectin for domestic animals and 4) behaviour change communication strategy to complement the universal coverage with LLINs through a cluster randomized trial.

Conditions

Interventions

DEVICE

Indoor residual sprayings

Houses will be spayed with this formulation containing Pyrimiphos methyl.

DEVICE

Larvicide

Larval breeding sites will be treated with larvicide

BEHAVIORAL

BCC

BIOLOGICAL

Ivermectin

Sponsors & Collaborators

  • Institut de Recherche en Sciences de la Sante, Burkina Faso

    collaborator OTHER_GOV

  • Institut Pierre Richet

    collaborator OTHER_GOV

  • Institut de Recherche pour le Developpement

    lead OTHER_GOV

Principal Investigators

  • Cédric Pennetier, PhD · Institut de Rehcerche pour le Développement

  • Nicolas Moiroux, PhD · Institut de Recherche pour le Developpement

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • Burkina Faso
  • Côte d’Ivoire

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03074435 on ClinicalTrials.gov